Clinical Trial Update: The VIRTUE Post Marketing Surveillance Registry

View source ↗

Summary

The VIRTUE post-marketing surveillance registry by Medtronic Endovascular completed, with results posted in 2013, monitoring outcomes for aortic dissection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Dissection

Snippet

Sponsor: Medtronic Endovascular | Conditions: Aortic Dissection | Status: COMPLETED | Results posted: 2013-12-11